CLINICAL_TRIALS
withdrawal
· 2024-02-06
Clinical Trial Update: The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus [Phase 3]
Summary
A Phase 3 trial evaluating ketamine as an adjuvant therapy for acute status asthmaticus in children has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Augusta University | Conditions: Status Asthmaticus | Phase 3 | Status: WITHDRAWN